Salvia Jain

11PUBLICATIONS
119CO-AUTHORS
Predictive and prognostic markersHaematological tumoursChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 05, 2025
Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.

Mark N Sorial, Luis E Malpica Castillo, Carlos Chiattone

|Jun 17, 2025
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas.

Josie G Ford, Min Jung Koh, Alexandra W Lenart

|May 01, 2025
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.

Mark N Sorial, Jessy Xinyi Han, Min Jung Koh

|Oct 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.

Jessy Xinyi Han, Min Jung Koh, Leora Boussi

|Jan 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Bimarzhan Assatova, Robert Willim, Christopher Trevisani

|Sep 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.

Gongwei Wu, Noriaki Yoshida, Jihe Liu

Pageof 2

Frequent Collaborators

6 joint publications

Robert Stuver

5 joint publications

Min Jung Koh

4 joint publications

Mark Sorial

4 joint publications

Francine M Foss